On February 7, 2024, H2U Corp. closed the transaction. The company announced that it has received 300,000 common shares at an issue price of KRW 4,316.883233 per share for the gross proceeds of KRW 1,295,064,970.

The transaction will include participation from new investor InnoTherapy, Inc, hold 8.96% stake in the company.